Nuclear Radiology: Page 18

U.K. staffing crisis deepens, RCR asserts
By Philip Ward
Workforce shortages in clinical radiology are increasing year-on-year, resulting in delayed diagnoses and lower-quality patient care, according to the latest annual census from the U.K. Royal College of Radiologists (RCR). Shortages of interventional and breast radiologists are an area of particular concern.
April 20, 2020
2019 11 01 16 57 7619 Ct Scan Patient 400
Incidental COVID-19 findings seen on routine FDG-PET/CT
By Wayne Forrest
Nuclear medicine practitioners should be prepared for incidental findings of COVID-19 when patients undergo FDG-PET/CT scans for routine oncologic indications, according to a study published online on 1 April in the Journal of Nuclear Medicine.
April 2, 2020
2020 04 02 22 53 2693 2020 04 02)covid 19 Fdg Pet Ct Jnm Albano Image G 400
Chinese team uses PET/CT on COVID-19 patients
By Wayne Forrest
Four patients with suspected COVID-19 underwent FDG-PET/CT at a Chinese hospital. The authors presented their findings online in the European Journal of Nuclear Medicine and Molecular Imaging on 25 March.
April 1, 2020
2020 02 12 18 38 0515 Virus Coronavirus2 400
IAEA publishes SPECT/CT usage guide
By AuntMinnieEurope.com staff writers
The International Atomic Energy Agency (IAEA) has published a quality control guide for SPECT/CT for nuclear medicine physicists, specialists, and radiation technologists.
March 29, 2020
2019 11 06 21 06 2992 Nuclear Medicine Gamma Camera 400
PET can help predict survival in prostate cancer
By Wayne Forrest
German and Swiss researchers have developed a PET-based risk classification metric for prostate cancer patients to help predict their survival without disease recurrence. They published their findings on 16 March in the European Journal of Nuclear Medicine and Molecular Imaging.
March 22, 2020
2016 10 04 11 38 34 158 Prostate 400
10 key actions to implement molecular radiotherapy
By Philip Ward
A European team of nuclear medicine specialists has proposed a 10-point plan to overcome the barriers to the clinical implementation of molecular radiotherapy. The plan was published online on 13 March by the European Journal of Nuclear Medicine and Molecular Imaging.
March 22, 2020
2020 03 20 17 20 3853 Cancer Radiotherapy 400
FDG-PET helps forecast outcome in neuroendocrine tumors
By Wayne Forrest
FDG-PET/CT can be used to classify neuroendocrine tumor patients into different prognostic categories for peptide receptor radionuclide therapy, German researchers have found. The decision to perform FDG-PET/CT should be based on the grading, time course of the disease, speed of progression, total tumor mass, and other criteria, they say.
March 19, 2020
2019 12 13 19 51 1879 Carcinoid Neuroendocrine Tumor 400
RLG issues statement on transporting radiopharmaceuticals
By AuntMinnieEurope.com staff writers
Radiopharmaceutical firm Radio Pharma Logistics Group (RLG) has pledged to continue to transport radiopharmaceuticals for its national and international clients, despite the substantial challenges posed by the novel coronavirus outbreak.
March 17, 2020
PET tracks down causes of fever in children
By Tami Freeman, PhD
In children with fever of unknown origin, imaging studies are scarce and the usefulness of FDG-PET/CT remains uncertain. Now a Dutch team has examined a large group of children in an attempt to fill the knowledge void.
March 12, 2020
2020 03 12 18 48 4411 2020 03 13 Pet Fever 20200312182919
Eckert & Ziegler begins production of lutetium-177
By AuntMinnieEurope.com staff writers
Isotope technology developer Eckert & Ziegler said it has begun commercial production of carrier-free lutetium-177.
March 10, 2020
European groups sponsor hybrid imaging fellowship
By AuntMinnieEurope.com staff writers
The European School of Radiology (ESOR) and the European Society for Hybrid, Molecular and Translational Imaging (ESHIMT) are receiving applications for its hybrid imaging fellowship program.
March 8, 2020
2020 03 09 20 45 0805 Pet Ct Machine 400
Framatome, Kinectrics partner on Lu-177
By AuntMinnieEurope.com staff writers
French nuclear reactor firm Framatome and Toronto-based Kinectrics have launched a joint venture, called Isogen, to provide support for the production of the medical isotope lutetium-177 (Lu-177).
March 4, 2020
2020 01 08 19 05 8090 Business Hands 400
Previous Page
Page 18 of 90
Next Page